When medications haven't worked, two breakthrough treatments — Spravato® and TMS — often can. Covered by all New Jersey insurance plans, delivered by a real care team across 12 New Jersey locations.
Two treatments. One care team. A clear path forward — without trial-and-error medication switches.
Spravato is FDA-approved and TMS is FDA-cleared — both specifically for treatment-resistant depression. Most patients see meaningful improvement within weeks.
Targeted neuro-treatments that don't add to your daily pill regimen — designed for people whose medications haven't delivered relief.
We work with Aetna, Cigna, Horizon BCBS, United, Medicare and more — verifying your benefits before your first appointment.
Sessions fit into a lunch break — most appointments run 20–60 minutes, in-office across our 12 New Jersey locations.
Submit your ZIP and a few details. A real human from our care team — not a chatbot — calls you back, usually within one business day.
We verify your coverage, explain what's included, and walk you through everything before your first appointment.
At your first appointment, our clinical team reviews your full history — past medications, response patterns, lifestyle, side-effect tolerance — and recommends the path most likely to work for your depression.
Some people are better candidates for Spravato; others for TMS. We help you decide together, with no pressure either way.
Whichever path fits, you'll be supported by the same care team from day one through the full course. Both treatments are delivered in-office, with no driving restrictions for TMS and short post-session monitoring for Spravato.
Self-administered nasal spray under clinical supervision. Most patients begin to feel relief within days.
Targeted magnetic pulses to the area of the brain involved in mood. Non-invasive, awake, no anesthesia, no recovery time.
Over 300 million lives are covered for these treatments — including the carriers most New Jersey residents already have.
…and many more. We'll verify your coverage before your first appointment.
The landmark STAR*D trial — the largest depression study ever conducted — shows what every patient with treatment-resistant depression already knows: switching pills again is unlikely to work.
Source: STAR*D Trial · Rush AJ et al., Am J Psychiatry, 2006. Cumulative remission rates after each treatment step.
The future of depression therapy is here, right now. Request a free, no-obligation consultation — we'll handle the rest.
If it is between Mon–Fri 8:30 AM – 6 PM, an intake specialist will reach out to you momentarily. If outside of our hours, within 1 business day.
…and many more. We verify your specific coverage before your first appointment.
